Stockscreener 앱 받기
2.29
2.35%
-0.055
시간 외 거래:
2.30
0.010
+0.44%
전일 마감가:
$2.345
열려 있는:
$2.34
하루 거래량:
60,035
Relative Volume:
0.37
시가총액:
$4.56M
수익:
$24.09M
순이익/손실:
$-4.51M
주가수익비율:
-1.3631
EPS:
-1.68
순현금흐름:
$-9.56M
1주 성능:
-12.26%
1개월 성능:
-23.92%
6개월 성능:
-87.69%
1년 성능:
-99.57%
1일 변동 폭
$2.27
$2.38
1주일 범위
$2.25
$2.73
52주 변동 폭
$2.25
$637.20
Sunshine Biopharma Inc Stock (SBFM) Company Profile
명칭
Sunshine Biopharma Inc
전화
954-515-0810
주소
333 LAS OLAS WAY, FORT LAUDERDALE
SBFM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| SBFM | 2.29 | 4.56M | 24.09M | -4.51M | -9.56M | -1.68 |
| ZTS | 176.42 | 79.51B | 9.15B | 2.43B | 2.31B | 4.92 |
| TAK | 13.53 | 42.89B | 30.27B | 1.93B | 3.45B | 0.444 |
| HLN | 9.43 | 42.57B | 14.26B | 1.55B | 0 | 0.3327 |
| TEVA | 16.49 | 18.51B | 16.77B | -959.00M | 1.37B | -2.00 |
| VTRS | 13.00 | 15.37B | 15.24B | -646.50M | 1.88B | 1.53 |
Sunshine Biopharma Inc 주식(SBFM)의 최신 뉴스
Sunshine Biopharma Inc. Warrant (SBFMW) Quarterly 10-Q Report - Quartz
Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54% - AccessWire
Sunshine Biopharma Q3 Revenue Surges 42% to $8.4M Despite Widening Losses | SBFM Stock News - StockTitan
SBFM (Sunshine Biopharma) Shares Outstanding (EOP) : 1.17 Mil (As of Jun. 2024) - GuruFocus.com
Canopy Growth Corporation (CGC) Stock Declines Amid Financial Re - GuruFocus.com
Bloomin’ Brands (NASDAQ:BLMN) Rating Increased to Hold at StockNews.com - Defense World
StockNews.com Begins Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World
DBV Technologies (NASDAQ:DBVT) Research Coverage Started at StockNews.com - Defense World
JATT Acquisition (NYSE:JATT) Trading Down 2.7% – Should You Sell? - Defense World
Sunshine Biopharma Strengthens Leadership with New Executive Agreements - TipRanks
Elanco Animal Health (ELAN) Stock Drops 5% Amidst Industry Decli - GuruFocus.com
Sunshine Biopharma, Inc. (NASDAQ:SBFM) Short Interest Up 66.8% in September - MarketBeat
Sunshine Biopharma announces Nora Pharma launch of two new generic drugs - TipRanks
Sunshine Biopharma expands generic drug portfolio - Investing.com
Sunshine Biopharma’s Nora Pharma launches two generic prescription drugs - TipRanks
Sunshine Biopharma Launches Two New Generic Prescription Drugs - AccessWire
A new trading data show Sunshine Biopharma Inc (SBFM) is showing positive returns. - SETE News
Sunshine Biopharma Inc (SBFM) Stock: Navigating a Year of Volatility - The InvestChronicle
How is SBFM’s stock performing after recent trades? - US Post News
Sunshine Biopharma meets Nasdaq compliance requirements By Investing.com - Investing.com Australia
Sunshine Biopharma meets Nasdaq compliance requirements - Investing.com
Sunshine Biopharma announces publication of coronavirus research results - TipRanks
Sunshine Biopharma reports potential SARS-CoV-2 treatment By Investing.com - Investing.com Canada
Sunshine Biopharma reports potential SARS-CoV-2 treatment - Investing.com
Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry - Lelezard
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth - GlobeNewswire
Is Sunshine Biopharma, Inc. (SBFM) The Best Rated Penny Stock To Buy According to Analysts? - MSN
10 Best Rated Penny Stocks To Buy According to Analysts - Insider Monkey
Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada - AccessWire
Sunshine Biopharma’s Revenues and Profits Surge - TipRanks
SBFM (Sunshine Biopharma) Operating Income : $-4.31 Mil (TTM As of Mar. 2024) - GuruFocus.com
Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61% - AccessWire
Sunshine Biopharma (NASDAQ:SBFM) Issues Quarterly Earnings Results - Defense World
Sunshine Biopharma (NASDAQ:SBFM) Shares Down 9.6% - MarketBeat
SBFM (Sunshine Biopharma) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Mar. 2024) - GuruFocus.com
SBFM (Sunshine Biopharma) Cyclically Adjusted PS Ratio : 0.00 (As of Aug. 16, 2024) - GuruFocus.com
SBFM (Sunshine Biopharma) Financial Strength : 7 (As of Mar. 2024) - GuruFocus.com
SBFM (Sunshine Biopharma) Long-Term Debt & Capital Lease Ob - GuruFocus.com
Sunshine Biopharma enacts 1-for-20 reverse stock split By Investing.com - Investing.com Australia
Sunshine Biopharma enacts 1-for-20 reverse stock split - Investing.com
Sunshine Biopharma stock hits 52-week low at $0.15 - Investing.com
SBFM’s Stock Performance: A Year of Mixed Fortunes & Market Shifts - The InvestChronicle
How does Sunshine Biopharma Inc (SBFM) change from a tortoise to a hare? - SETE News
Technical analysis of Sunshine Biopharma Inc (SBFM) stock chart patterns - US Post News
Sunshine Biopharma Announces Reverse Stock Split - StockTitan
It makes sense and dollars to buy Sunshine Biopharma Inc (SBFM) stock - SETE News
Anchoring Your Portfolio: Is SBFM Stock a Safe Harbor? - The InvestChronicle
A stock that deserves closer examination: Sunshine Biopharma Inc (SBFM) - US Post News
Ratio Examination: Sunshine Biopharma Inc (SBFM)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Are Smart Investors Making the Right Decision? Sunshine Biopharma Inc (SBFM) - SETE News
Stock Surge: Sunshine Biopharma Inc (SBFM) Closes at 0.30, Marking a -5.82 Increase/Decrease - The Dwinnex
Sunshine Biopharma Inc (SBFM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.79%
0.15%
자본화:
|
볼륨(24시간):